Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395213 · ClinicalTrials.gov registry record
Antidepressant Safety in Kids Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 569
- Enrollment target
NCT00395213: Completed study, sponsored by Duke University.
NCT00395213 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 569 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00395213 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 569 participants
- Enrollment target
Study Summary
This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder.
Interventions
- DRUG Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 569 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-07 |
What the finished NCT00395213 record still lists
NCT00395213 is an observational study that tracks outcomes without assigning an intervention. The registered 569 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications is the first listed.
NCT00395213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00395213 about?
NCT00395213 is a clinical study titled "Antidepressant Safety in Kids Study". This study will evaluate the risks and benefits of treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor in children and adolescents with a pre-specified anxiety disorder, depressive disorder, eating disorder, or obsessive-compulsive disorder.
What is the current status of trial NCT00395213?
This trial is currently completed. The enrollment target is 569 participants. The study started on 2007-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00395213?
The interventions under investigation include: Selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications (DRUG).
Who is sponsoring clinical trial NCT00395213?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia